| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Mark J Brookner last filed a Form 4 in November 2022, as Director at USPH. From May 2015 to November 2022, the filings on record show 0 open-market purchases and 21 sales. Mark J Brookner's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Mark J Brookner a middling insider score of 58/100, based on 4 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +5.7%.
At the last filing, the largest reported position was 13,830 shares of USPH. The USPH filings lean toward selling, a net 36,950 shares.
Shares as reported in the last Form 4 for each company; the most recent is from November 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2017 | USPH U S Physical Therapy Inc /nv | Director | Sell | 2,625 | $71.23 | $186,990.00 | -5.1% |